The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands. (Record no. 27493777)

MARC details
000 -LEADER
fixed length control field 01600 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517171418.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201808s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1941-837X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1080/13696998.2017.1372222
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name van Hulst, Marinus
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20180822
245 00 - TITLE STATEMENT
Title The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of medical economics
Date of publication, distribution, etc. Jan 2018
300 ## - PHYSICAL DESCRIPTION
Extent 38-46 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antithrombins
General subdivision economics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Atrial Fibrillation
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cohort Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cost-Benefit Analysis
General subdivision economics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dabigatran
General subdivision economics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Markov Chains
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Netherlands
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quality-Adjusted Life Years
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Risk Assessment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thromboembolism
General subdivision etiology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vitamin K
General subdivision administration & dosage
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stevanovic, Jelena
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jacobs, Maartje S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tieleman, Robert G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kappelhoff, Bregt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Postma, Maarten J
773 0# - HOST ITEM ENTRY
Title Journal of medical economics
Related parts vol. 21
-- no. 1
-- p. 38-46
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1080/13696998.2017.1372222">https://doi.org/10.1080/13696998.2017.1372222</a>
Public note Available from publisher's website

No items available.